Mary Elliott

4.3k total citations · 2 hit papers
94 papers, 3.4k citations indexed

About

Mary Elliott is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Orthopedics and Sports Medicine. According to data from OpenAlex, Mary Elliott has authored 94 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Molecular Biology and 22 papers in Orthopedics and Sports Medicine. Recurrent topics in Mary Elliott's work include Hormonal Regulation and Hypertension (23 papers), Bone health and osteoporosis research (22 papers) and Lipoproteins and Cardiovascular Health (12 papers). Mary Elliott is often cited by papers focused on Hormonal Regulation and Hypertension (23 papers), Bone health and osteoporosis research (22 papers) and Lipoproteins and Cardiovascular Health (12 papers). Mary Elliott collaborates with scholars based in United States, Canada and United Kingdom. Mary Elliott's co-authors include Theodore L. Goodfriend, Kevin Catt, Steven A. Atlas, Neil Binkley, David Preiss, Scott M. Wasserman, Naveed Sattar, Richard J. Schimmel, Colin R. Jefcoate and Christie M. Ballantyne and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Mary Elliott

91 papers receiving 3.2k citations

Hit Papers

Health and social care in the community 1989 2026 2001 2013 1989 2016 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Health and social care in the community
    1989 824 citations Mary Elliott profile →
  2. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance
    2016 354 citations Erik S.G. Stroes, Robert S. Rosenson et al. profile →

Peers

Mary Elliott
Randi Selmer Norway
Catherine M. Viscoli United States
S. B. Hulley United States
Lucile L. Adams‐Campbell United States
John McKnight United Kingdom
Trudy L. Bush United States
Kari Furu Norway
Rebecca J. Mullan United States
F. Allan Hubbell United States
Antonio Cano Spain
Randi Selmer Norway
Mary Elliott
Citations per year, relative to Mary Elliott Mary Elliott (= 1×) peers Randi Selmer

Countries citing papers authored by Mary Elliott

Since Specialization
Citations

This map shows the geographic impact of Mary Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Elliott more than expected).

Fields of papers citing papers by Mary Elliott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Elliott. The network helps show where Mary Elliott may publish in the future.

Co-authorship network of co-authors of Mary Elliott

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Elliott. A scholar is included among the top collaborators of Mary Elliott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Elliott. Mary Elliott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hall, Amanda K., et al.. (2023). An Administrative Approach for Special Educator Retention. Murray State's Digital Commons (Murray State University). 9(1). 1 indexed citations
2.
Barry, Aisling, et al.. (2020). Time to “Buddy Up”—Simple Strategies to Support Oncologists During the Coronavirus Disease 2019 Pandemic. Advances in Radiation Oncology. 5(4). 601–602. 5 indexed citations
3.
Jiang, Di, Alejandro Berlín, Lesley Moody, et al.. (2020). Transitioning to a New Normal in the Post-COVID Era. Current Oncology Reports. 22(7). 73–73. 12 indexed citations
4.
Nissim, Rinat, et al.. (2019). Mindfulness-Based Cognitive Therapy Intervention for Young Adults with Cancer: A Pilot Mixed-Method Study. Journal of Adolescent and Young Adult Oncology. 9(2). 256–261. 6 indexed citations
5.
Preiss, David, Dirk Blom, C. Stephen Djedjos, et al.. (2015). Evaluation of the one-year efficacy, safety and glycaemic effects of evolocumab (AMG 145) in 4,802 subjects with, at high risk for, or at low risk for, diabetes mellitus. Diabetologia. 58. 6 indexed citations
6.
Elliott, Mary, et al.. (2015). Improving treatment outcomes for HIV-positive Aboriginal and Torres Strait Islander people at Cairns Sexual Health using the treatment cascade as a model. 13(3). 36. 1 indexed citations
7.
Sattar, Naveed, C. Stephen Djedjos, J Robinson, et al.. (2015). Efficacy and Safety of the PCSK9 Inhibitor Evolocumab (AMG 145) in Patients with Type 2 Diabetes. Diabetes. 64. 4 indexed citations
8.
Preiss, David, Naveed Sattar, J Robinson, et al.. (2015). Efficacy of one year of treatment with the PCSK9 inhibitor evolocumab (AMG 145) in 4,802 subjects with or without type 2 diabetes. Diabetologia. 58.
9.
Koren, Michael J., Robert S. Rosenson, Bobby V. Khan, et al.. (2015). LDL CHOLESTEROL REDUCTION IN ELDERLY PATIENTS WITH THE PCSK9 MONOCLONAL ANTIBODY EVOLOCUMAB (AMG 145): A POOLED ANALYSIS OF 1779 PATIENTS IN PHASE 2, 3 AND OPEN LABEL EXTENSION STUDIES. Journal of the American College of Cardiology. 65(10). A1366–A1366. 6 indexed citations
10.
Danielson, Kirstie K., Mary Elliott, Tamara J. LeCaire, Neil Binkley, & Mari Palta. (2008). Poor glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetes. Osteoporosis International. 20(6). 923–933. 68 indexed citations
11.
Elliott, Mary, et al.. (2007). Patient Assessment in the Diagnosis, Prevention, and Treatment of Osteoporosis. Nutrition in Clinical Practice. 22(3). 261–275. 10 indexed citations
12.
Elliott, Mary, et al.. (2004). The Role of Vitamin D in the Prevention and Treatment of Osteoporosis. Clinical Reviews in Bone and Mineral Metabolism. 2(4). 373–388. 5 indexed citations
13.
Mommsen, T. P., Ellen R. Busby, Kristian R. von Schalburg, et al.. (2003). Glutamine synthetase in tilapia gastrointestinal tract: zonation, cDNA and induction by cortisol. Journal of Comparative Physiology B. 173(5). 419–427. 30 indexed citations
14.
Elliott, Mary, et al.. (2003). Risk for Osteoporosis in Elderly Nuns: Need for Better Recognition and Treatment. Current Therapeutic Research. 64(2). 65–80. 2 indexed citations
15.
Binkley, Neil, et al.. (2002). Acceptability of pharmacy-based bone density measurement by women and primary healthcare providers. Menopause The Journal of The North American Menopause Society. 9(6). 449–455. 24 indexed citations
16.
Joubert, David, et al.. (2001). Physical sequelae and self‐perceived attachment in adult survivors of childhood cancer. Psycho-Oncology. 10(4). 284–292. 20 indexed citations
17.
18.
Macnab, Andrew, et al.. (1996). Midazolam following open heart surgery in children: haemodynamic effects of a loading dose. Pediatric Anesthesia. 6(5). 387–397. 4 indexed citations
19.
Elliott, Mary, et al.. (1991). Sphingosine inhibits angiotensin-stimulated aldosterone synthesis. The Journal of Steroid Biochemistry and Molecular Biology. 38(4). 475–481. 3 indexed citations
20.
Elliott, Mary. (1990). Phosphorylation of adrenal histone H3 is affected by angiotensin, ACTH, dibutyryl cAMP, and atrial natriuretic peptide. Life Sciences. 46(20). 1479–1488. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Randi Selmer Breakdown of academic impact, for papers by Catherine M. Viscoli Breakdown of academic impact, for papers by S. B. Hulley Breakdown of academic impact, for papers by Lucile L. Adams‐Campbell Breakdown of academic impact, for papers by John McKnight Breakdown of academic impact, for papers by Trudy L. Bush Breakdown of academic impact, for papers by Kari Furu Breakdown of academic impact, for papers by Rebecca J. Mullan Breakdown of academic impact, for papers by F. Allan Hubbell Breakdown of academic impact, for papers by Antonio Cano
Rankless by CCL
2026